Colorcon invests in new film coating manufacturing plant in Brazil
Production of commercial-scale product scheduled for January 2017.
Colorcon has announced its investment in a new film coating manufacturing plant in Indaiatuba, São Paulo State, Brazil, supporting the continued growth of the pharmaceutical industry in South America. The construction is scheduled for completion by October 2016 with the production of commercial-scale product scheduled for January 2017. Strategically located, the site will produce GMP film coating products for the pharmaceutical and nutritional markets in South America, including Argentina, Brazil, Chile, Paraguay and Uruguay
Martti Hedman, CEO, Colorcon Inc. explains the significance of Colorcon’s investment as another example of our strategy to position manufacturing facilities close to our customers. “We want to make it easy for customers to work with Colorcon. This facility allows our customers to take advantage of shorter lead times on all of our film coating products, and reduces the risk of importation delays. In addition, the Indaiatuba facility is another important step in further securing the supply chain for our customers, by providing a South American component in Colorcon’ s Business Continuity Plan, with the capability to supply and export film coatings with the same quality, consistency and equivalency for product manufactured in our other six production plants around the world.”
Perry Cozzone, President – Americas added: “Colorcon is committed to providing the highest quality products and superior service to meet our customer's needs around the world. This investment reinforces our dedication to providing exceptional support we believe our customers deserve while providing greater flexibility in the scheduling of their production, ultimately leading to their products reaching the market faster.”
Colorcon Brazil will continue to support customers across the region with formulation and development of pharmaceutical products through the Technical Service Laboratory already established at Cotia, Sao Paulo. Originally opened in 2000, this support facility has continued to provide samples and applications support for over 16 years in the region.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance